Authors
Loading...
Randomized trial explores S100A4's role in collective invasion in pancreatic ductal adenocarcinoma, indicating a new therapeutic target.
Son et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: